PRESS RELEASE published on 06/10/2026 at 00:00, 3 months 2 days ago Terms of availability of the preparatory documents for the GM ABL Diagnostics (ABLD) discloses information on total voting rights and share capital composition as per regulatory requirements. The company specializes in molecular biology tests and global solutions for academic labs, private labs, and researchers Share Capital Voting Rights Regulatory Disclosure ABL Diagnostics Molecular Biology Tests
PRESS RELEASE published on 06/10/2026 at 00:00, 3 months 2 days ago Modalités de mise à disposition des documents préparatoires à l'AG ABL Diagnostics (ABLD) est une société internationale spécialisée dans les tests de biologie moléculaire innovants. Son siège est à Woippy. Elle est cotée sur Euronext Paris Euronext Paris Biologie Moléculaire ABL Diagnostics Innovants Woippy
BRIEF published on 06/09/2026 at 19:05, 3 months 2 days ago ABL Diagnostics is preparing for its General Assembly on June 30, 2026 Investors General Assembly Preparatory Documents Molecular Biology ABL Diagnostics
BRIEF published on 06/09/2026 at 19:05, 3 months 2 days ago ABL Diagnostics prépare son Assemblée Générale du 30 juin 2026 Assemblée Générale Investisseurs Documents Préparatoires Biologie Moléculaire ABL Diagnostics
BRIEF published on 06/09/2026 at 19:05, 3 months 2 days ago ABL Diagnostics Announces General Meeting on June 30, 2026 Shareholders Financial Statements Paris General Meeting ABL Diagnostics
BRIEF published on 06/09/2026 at 19:05, 3 months 2 days ago ABL Diagnostics annonce la tenue de son assemblée générale le 30 juin 2026. Actionnaires Paris Assemblée Générale États Financiers Diagnostics ABL
PRESS RELEASE published on 06/09/2026 at 19:00, 3 months 2 days ago Modalités de mise à disposition des documents préparatoires à l'AG ABL Diagnostics convoque ses actionnaires en Assemblée Générale le 30 juin 2026 pour statuer sur les comptes annuels. Des tests de biologie moléculaire et solutions globales sont proposés Assemblée Générale Comptes Annuels ABL Diagnostics Solutions Globales Tests De Biologie Moléculaire
PRESS RELEASE published on 06/09/2026 at 19:00, 3 months 2 days ago Terms of availability of the preparatory documents for the GM ABL Diagnostics invites shareholders to the Ordinary and Extraordinary General Meeting on June 30, 2026, to discuss annual financial statements and more. Consult documents on company's website Shareholders Financial Statements General Meeting Molecular Biology ABL Diagnostics
BRIEF published on 05/08/2026 at 00:06, 4 months 4 days ago ABL Diagnostics Publishes its 2025 Annual Financial Report Euronext Paris General Assembly Molecular Biology ABL Diagnostics Financial Report 2025
BRIEF published on 05/08/2026 at 00:06, 4 months 4 days ago ABL Diagnostics Publie son Rapport Financier Annuel 2025 Euronext Paris Assemblée Générale Biologie Moléculaire ABL Diagnostics Rapport Financier 2025
Published on 09/12/2026 at 02:35, 11 hours 15 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 50 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 45 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 25 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 50 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 20 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 35 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 40 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 6 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 35 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
